1
|
Wang R, Qi YF, Ding CH, Zhang D. Sulfur-containing amino acids and their metabolites in atrial fibrosis. Front Pharmacol 2022; 13:1063241. [DOI: 10.3389/fphar.2022.1063241] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2022] [Accepted: 10/24/2022] [Indexed: 11/06/2022] Open
Abstract
Atrial fibrosis, a symbol of atrial structural remodelling, is a complex process involved in the occurrence and maintenance of atrial fibrillation (AF). Atrial fibrosis is regulated by multiple factors. Sulfur containing amino acids and their metabolites, such as hydrogen sulfide (H2S) and taurine, can inhibit the process of atrial fibrosis and alleviate atrial remodeling. However, homocysteine can promote the activation of atrial fibroblasts and further promote atrial fibrosis. In this review, we will focus on the recent progress in atrial structural changes and molecular mechanisms of atrial fibrosis, as well as the regulatory roles and possible mechanisms of sulfur containing amino acids and their metabolites in atrial fibrosis. It is expected to provide new ideas for clarifying the mechanism of atrial fibrosis and finding targets to inhibit the progress of atrial fibrosis.
Collapse
|
2
|
Mauro E, Lucà F, Tetta C, Parise O, Parrini I, Parise G, Rao CM, Matteucci F, Micali LR, Gulizia MM, La Meir M, Gelsomino S. Breast Cancer and Atrial Fibrillation. J Clin Med 2022; 11:jcm11051417. [PMID: 35268508 PMCID: PMC8911432 DOI: 10.3390/jcm11051417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2021] [Revised: 02/16/2022] [Accepted: 03/01/2022] [Indexed: 02/01/2023] Open
Abstract
This study aims to establish the incidence of atrial fibrillation (AF) in breast cancer (BC) patients, focusing on staging and anti-cancer treatment. A meta-analysis was conducted to investigate the incidence of AF in BC patients and compare this incidence to other cancers. Furthermore, we evaluated the occurrence of AF as an adverse effect of biological therapies vs. non-biological therapies vs. biological therapies + non-biological therapies in BC. Finally, we compared the incidence of AF in early BC and metastatic BC. Thirty studies were included. Twenty-two studies focused on BC, encompassing 166,271 patients. In the BC group, 2.7% of patients developed AF, while in the “all cancer” group, 5.8% of patients developed AF. In addition, there was no difference between different types of therapies (p = 0.61) and between early and metastatic BC (p = 0.57). The type of anti-cancer therapy and the staging of BC does not influence AF’s occurrence in this neoplastic disease.
Collapse
Affiliation(s)
- Emanuela Mauro
- Cardiothoracic Department, CARIM School for Cardiovascular Diseases, Maastricht University, 6229HX Maastricht, The Netherlands; (E.M.); (C.T.); (O.P.); (G.P.); (F.M.); (L.R.M.)
| | - Fabiana Lucà
- Cardiology Department, Grande Ospedale Metropolitano—GMO Hospital, 89124 Reggio Calabria, Italy; (F.L.); (C.M.R.)
| | - Cecilia Tetta
- Cardiothoracic Department, CARIM School for Cardiovascular Diseases, Maastricht University, 6229HX Maastricht, The Netherlands; (E.M.); (C.T.); (O.P.); (G.P.); (F.M.); (L.R.M.)
| | - Orlando Parise
- Cardiothoracic Department, CARIM School for Cardiovascular Diseases, Maastricht University, 6229HX Maastricht, The Netherlands; (E.M.); (C.T.); (O.P.); (G.P.); (F.M.); (L.R.M.)
| | - Iris Parrini
- Cardiology Department, Mauriziano Umberto I Hospital, 10128 Torino, Italy;
| | - Gianmarco Parise
- Cardiothoracic Department, CARIM School for Cardiovascular Diseases, Maastricht University, 6229HX Maastricht, The Netherlands; (E.M.); (C.T.); (O.P.); (G.P.); (F.M.); (L.R.M.)
| | - Carmelo Massimiliano Rao
- Cardiology Department, Grande Ospedale Metropolitano—GMO Hospital, 89124 Reggio Calabria, Italy; (F.L.); (C.M.R.)
| | - Francesco Matteucci
- Cardiothoracic Department, CARIM School for Cardiovascular Diseases, Maastricht University, 6229HX Maastricht, The Netherlands; (E.M.); (C.T.); (O.P.); (G.P.); (F.M.); (L.R.M.)
| | - Linda Renata Micali
- Cardiothoracic Department, CARIM School for Cardiovascular Diseases, Maastricht University, 6229HX Maastricht, The Netherlands; (E.M.); (C.T.); (O.P.); (G.P.); (F.M.); (L.R.M.)
| | - Michele Massimo Gulizia
- Cardiology Department, Garibaldi Nesima Hospital, 95123 Catania, Italy;
- Heart Care Foundation, Via Alfonso la Marmora 36, 50121 Firenze, Italy
| | - Mark La Meir
- Cardiothoracic Department, Brussels University Hospital, 1090 Brussels, Belgium;
| | - Sandro Gelsomino
- Cardiothoracic Department, CARIM School for Cardiovascular Diseases, Maastricht University, 6229HX Maastricht, The Netherlands; (E.M.); (C.T.); (O.P.); (G.P.); (F.M.); (L.R.M.)
- Cardiothoracic Department, Brussels University Hospital, 1090 Brussels, Belgium;
- Correspondence:
| |
Collapse
|
3
|
Zhou M, Wang H, Chen J, Zhao L. Epicardial adipose tissue and atrial fibrillation: Possible mechanisms, potential therapies, and future directions. PACING AND CLINICAL ELECTROPHYSIOLOGY: PACE 2019; 43:133-145. [DOI: 10.1111/pace.13825] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/08/2019] [Revised: 10/03/2019] [Accepted: 10/22/2019] [Indexed: 12/21/2022]
Affiliation(s)
- Mengmeng Zhou
- Department of Cardiology, Shanghai Chest HospitalShanghai Jiao Tong University Shanghai China
| | - Hao Wang
- Department of Cardiology, Shanghai Chest HospitalShanghai Jiao Tong University Shanghai China
| | - Jindong Chen
- Department of Cardiology, Shanghai Chest HospitalShanghai Jiao Tong University Shanghai China
| | - Liang Zhao
- Department of Cardiology, Shanghai Chest HospitalShanghai Jiao Tong University Shanghai China
| |
Collapse
|
4
|
Goudis CA, Vasileiadis IE, Liu T. Epicardial adipose tissue and atrial fibrillation: pathophysiological mechanisms, clinical implications, and potential therapies. Curr Med Res Opin 2018; 34:1933-1943. [PMID: 29625530 DOI: 10.1080/03007995.2018.1462786] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
BACKGROUND Atrial fibrillation (AF) is the most common arrhythmia in clinical practice and is associated with increased cardiovascular morbidity and mortality. Epicardial adipose tissue (EAT) serves as a biologically active organ with important endocrine and inflammatory function. Review An accumulating body of evidence suggests that EAT is associated with the initiation, perpetuation, and recurrence of AF, but the precise role of EAT in AF pathogenesis is not completely elucidated. Pathophysiological mechanisms involve adipocyte infiltration, profibrotic and pro-inflammatory paracrine effects, oxidative stress, neural mechanisms, and genetic factors. CONCLUSIONS Notably, EAT accumulation seems to be associated with stroke and adverse cardiovascular outcomes in AF. Weight loss, specific medications and ablation of ganglionated plexi (GP) seem to be potential therapies in this setting.
Collapse
Affiliation(s)
- Christos A Goudis
- a Department of Cardiology , Serres General Hospital , Serres , Greece
| | | | - Tong Liu
- c Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology , Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University , Tianjin , PR China
| |
Collapse
|
5
|
Rhee TM, Lee SR, Cha MJ, Choi EK, Oh S. Association of Complex Fractionated Electrograms with Atrial Myocardial Thickness and Fibrosis. INTERNATIONAL JOURNAL OF ARRHYTHMIA 2018. [DOI: 10.18501/arrhythmia.2018.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
6
|
Lackermair K, Clauss S, Voigt T, Klier I, Summo C, Hildebrand B, Nickel T, Estner HL, Kääb S, Wakili R, Wilbert-Lampen U. Alteration of Endothelin 1, MCP-1 and Chromogranin A in patients with atrial fibrillation undergoing pulmonary vein isolation. PLoS One 2017; 12:e0184337. [PMID: 28886122 PMCID: PMC5590904 DOI: 10.1371/journal.pone.0184337] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2017] [Accepted: 08/22/2017] [Indexed: 11/18/2022] Open
Abstract
BACKGROUND The relation between arrhythmias and stress is known. The aim of our current study was to elucidate whether plasma levels of previously described stress parameters are altered in highly symptomatic patients with atrial fibrillation (AF) per se and in patients undergoing ablation therapy by pulmonary vein isolation (PVI). METHODS 96 patients with AF undergoing PVI were recruited. Plasma levels of Endothelin-1 (ET-1), MCP-1 and Chromogranin-A (CGA) were measured before and three months after ablation completed with clinical follow-up with respect to AF recurrence. Additionally, we examined 40 healthy age- and sex-matched volunteers as a reference. RESULTS Symptomatic AF patients showed increased levels of ET-1 compared to healthy controls (2.62pg/ml vs. 1.57pg/ml; p<0.01). Baseline levels of ET-1 were higher in patients presenting with AF after PVI (2.96pg/ml vs. 2.57pg/ml;p = 0.02). The temporal comparison revealed decreased ET-1 levels in patients without (2.57pg/ml vs. 2.33pg/ml; p<0.01) and unchanged ET-1 levels in patients with AF after PVI. Baseline MCP-1 was increased in AF patients vs. controls (268pg/ml vs. 227 pg/ml; p = 0.03). Both groups, with and without AF after PVI, showed an increase of MCP-1 compared to baseline (268pg/ml vs. 349pg/ml;p<0.01; 281pg/ml vs. 355pg/ml;p = 0.03). CGA was lower in AF patients compared to healthy controls (13.8ng/ml vs. 25.6ng/ml;p<0.01). Over time patients without AF after PVI showed an increase of CGA (14.2ng/ml vs. 20.7ng/ml;p<0.01). No change was observed in patients with AF after PVI. CONCLUSION Our study demonstrated dysregulated levels of ET-1, MCP-1 and CGA in symptomatic AF patients. We could demonstrate an association between ET-1 to presence or absence of AF. Furthermore, we could show that a decrease of ET-1 as well as an increase of CGA after PVI, representing a trend towards control cohort levels, were both associated with restoration of sinus rhythm. These results provide new insights into the role of stress-related biomarkers in AF and AF treatment by ablation therapy.
Collapse
Affiliation(s)
- K. Lackermair
- Department of Medicine I, Klinikum Grosshadern, University of Munich (LMU), Munich, Germany
| | - S. Clauss
- Department of Medicine I, Klinikum Grosshadern, University of Munich (LMU), Munich, Germany
- DZHK (German Centre for Cardiovascular Research), Partner site Munich, Munich Heart Alliance, Munich, Germany
| | - T. Voigt
- Department of Medicine I, Klinikum Grosshadern, University of Munich (LMU), Munich, Germany
| | - I. Klier
- Department of Medicine I, Klinikum Grosshadern, University of Munich (LMU), Munich, Germany
| | - C. Summo
- Department of Medicine I, Klinikum Grosshadern, University of Munich (LMU), Munich, Germany
| | - B. Hildebrand
- Department of Medicine I, Klinikum Grosshadern, University of Munich (LMU), Munich, Germany
| | - T. Nickel
- Department of Medicine I, Klinikum Grosshadern, University of Munich (LMU), Munich, Germany
| | - H. L. Estner
- Department of Medicine I, Klinikum Grosshadern, University of Munich (LMU), Munich, Germany
| | - S. Kääb
- Department of Medicine I, Klinikum Grosshadern, University of Munich (LMU), Munich, Germany
| | - R. Wakili
- Department of Medicine I, Klinikum Grosshadern, University of Munich (LMU), Munich, Germany
- DZHK (German Centre for Cardiovascular Research), Partner site Munich, Munich Heart Alliance, Munich, Germany
- Department of Cardiology and Vascular Medicine, West-German Heart and Vascular Center Essen, University of Essen Medical School, University Duisburg-Essen, Essen, Germany
- * E-mail:
| | - U. Wilbert-Lampen
- Department of Medicine I, Klinikum Grosshadern, University of Munich (LMU), Munich, Germany
| |
Collapse
|